Technology and Equipment

Will AI generate new hypotheses and lead to repurposed failed drug candidates?

A century from now, will healthcare and medicine look like dystopia or utopia?

Some say lyophilization has changed little in over 70 years, but a new consortium hopes to help change that.

Cybersecurity is an aspect of business infrastructure that needs to be taken seriously.

Could body-on-chip platforms eventually replace current pre-clinical animal models?

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?

The FDA has approved a pill with the ability to track patient compliance.

To ensure that cell therapy manufacture runs smoothly, the industry must embrace automation.

Nominations close on November 10 for The Medicine Maker 2017 Innovation Awards.

A look a Millipore Sigma’s global network of collaboration facilities, ‘M-Lab’